Curative Biotechnology, Inc. (OTCMKTS:CUBT) Short Interest Update

Curative Biotechnology, Inc. (OTCMKTS:CUBT) saw a large decrease in short interest in the month of September. As of September 30th, there was short interest totalling 1,000 shares, a decrease of 97.4% from the September 15th total of 38,300 shares. Based on an average daily volume of 482,800 shares, the days-to-cover ratio is currently 0.0 days.

Curative Biotechnology Stock Performance

CUBT remained flat at $0.02 during midday trading on Friday. The company’s stock had a trading volume of 1,532,670 shares, compared to its average volume of 204,801. The company’s 50 day simple moving average is $0.01 and its 200-day simple moving average is $0.02. Curative Biotechnology has a 12-month low of $0.00 and a 12-month high of $0.04.

Curative Biotechnology Company Profile

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.